Thyrocare Board Approves Evaluation of Radiology Business Demerger

Thyrocare Technologies Ltd's Board of Directors has granted in-principle approval to evaluate a proposed restructuring of its wholly-owned subsidiary, Nuelear Healthcare Limited (NHL). NHL is involved in advanced cancer diagnostics, nuclear medicine, PET-CT and CT imaging, and radiopharmaceutical manufacturing. The restructuring could involve a demerger of NHL's radiology business undertaking outside the group, through mechanisms like a scheme of arrangement, slump sale, or business transfer. This evaluation is at an initial stage, and detailed terms will be presented to NHL's board later. The company will adhere to all regulatory requirements throughout the process.